Queen Mary University of London: Preparing for a World Where Alzheimer's Disease is Treatable
June 13, 2024
June 13, 2024
LONDON, England, June 13 (TNSres) -- Queen Mary University of London issued the following news:
Drugs with the potential to change the course of Alzheimer's disease are expected to be approved by mid-year in the UK. Healthcare services may need to change to ensure that all patients have equitable access to these new modifying anti-amyloid therapies.
Alzheimer's disease is the most common cause of dementia. Of the 944,000 people living with dementia in the UK, 60-80% hav . . .
Drugs with the potential to change the course of Alzheimer's disease are expected to be approved by mid-year in the UK. Healthcare services may need to change to ensure that all patients have equitable access to these new modifying anti-amyloid therapies.
Alzheimer's disease is the most common cause of dementia. Of the 944,000 people living with dementia in the UK, 60-80% hav . . .